Neomal S. Sandanayake

Sydney, NSW 2065, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis.

Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis.

Journal: JCI insight

Published: December 21, 2021

Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study.

Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 02, 2021

Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis.

Calcineurin inhibitors in steroid and anti-TNF-alpha refractory immune checkpoint inhibitor colitis.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 02, 2021

Life-threatening diarrhea in neuroendocrine tumors: two case reports.

Life-threatening diarrhea in neuroendocrine tumors: two case reports.

Journal: Journal of medical case reports

Published: November 19, 2020

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab.

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab.

Journal: Journal for immunotherapy of cancer

Published: November 02, 2020

Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy.

Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 20, 2016

Gastrointestinal: Intractable delayed gastrointestinal bleeding after pancreatoduodenectomy.

Gastrointestinal: Intractable delayed gastrointestinal bleeding after pancreatoduodenectomy.

Journal: Journal of gastroenterology and hepatology

Published: August 18, 2016

Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.

Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 19, 2014

Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.

Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.

Journal: BMC clinical pathology

Published: July 13, 2013

Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.

Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.

Journal: Journal of clinical and experimental hepatology

Published: January 10, 2012

Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.

Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.

Journal: Cancer

Published: December 21, 2011

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.

A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.

Journal: British journal of cancer

Published: October 06, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026